Head of U.S. Compliance – MorphoSys
Amy Wilson brings her ability as a strategic collaborator to MorphoSys US. She works to bolster business decision-making and performance management through the development and implementation of a foundational compliance management program.
Amy has more than 25 years of experience in the life sciences industry. She contributes proven technical compliance expertise that is informed by extensive brand sales, marketing, and operations experience.
Prior to joining MorphoSys US, Amy served as Enterprise Compliance Lead at Alexion. She also held the position of Compliance Monitoring and Risk Lead at Takeda. Leading up to her more recent compliance experiences, Amy worked in escalating sales, marketing, and patient support services roles at Eisai and Novartis.
In support of her evolving career, Amy most recently earned a master’s in jurisprudence from Seton Hall University School of Law. She also holds a bachelor of science from Drexel University and an MBA from Fairleigh Dickinson University.